Lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, downregulates thymidylate synthase by inhibiting the nuclear translocation of EGFR and HER2.
(Q33468432)
scientific article
scientific article
Language:
Current Data About
Lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, downregulates thymidylate synthase by inhibiting the nuclear translocation of EGFR and HER2.
other details
description | scientific article |
External Links
(P356) |
10.1371/JOURNAL.PONE.0005933
|
(P698) |
19529774
|
(P819) |
2009PLoSO...4.5933K
|
(P932) |
2691960
|
(P5875) |
26295108
|